Skip to content
- Prostate cancer and novel pharmacological treatment options - what's new for 2022?
- Marchetti A, Tassinari E, Rosellini M, Rizzo A, Massari F, Mollica V.
- Expert Rev Clin Pharmacol. 2023 Feb 15. doi: 10.1080/17512433.2023.2181783. Epub ahead of print.
- Management of patients with advanced epithelial ovarian cancer: a European survey.
- Jochum F, Angeles MA, Balaya V, Drouin L, Nikolova T, Mathevet P, Lécuru F, Azais H, Betrian S, Bolze PA, Dabi Y, Kerbage Y, Sanson C, Zaccarini F, Guyon F, Akladios C, Hsu A, Bendifallah S, Deluche E, Guani B.
- Arch Gynecol Obstet. 2023 Feb 3. doi: 10.1007/s00404-023-06948-3. Epub ahead of print.
- Efficacy of Olaparib in Treatment-Refractory, Metastatic Breast Cancer with Uncommon Somatic BRCA Mutations Detected in Circulating Tumor DNA.
- Yoon JK, Ahn J, Kim S, Kim HP, Kang JK, Bang D, Lim Y, Kim TY.
- Cancer Res Treat. 2023 Jan 31. doi: 10.4143/crt.2022.1529. Epub ahead of print.
- Systemic Therapies for Metastatic Castration-Resistant Prostate Cancer: An Updated Review.
- Hatano K, Nonomura N.
- World J Mens Health. 2023 Jan 27. doi: 10.5534/wjmh.220200. Epub ahead of print.
- Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types.
- Zannini G, Facchini G, De Sio M, De Vita F, Ronchi A, Orditura M, Vietri MT, Ciardiello F, Franco R, Accardo M, Zito Marino F.
- Pathol Res Pract. 2023 Jan 23;243:154336. doi: 10.1016/j.prp.2023.154336. Epub ahead of print.